These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 23983923)

  • 1. Melperone in treatment-refractory schizophrenia: a case series.
    Whiskey E; Vavrova M; Gaughran F; Taylor D
    Ther Adv Psychopharmacol; 2011 Feb; 1(1):19-23. PubMed ID: 23983923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in weight and body mass index during treatment with melperone, clozapine and typical neuroleptics.
    Bobo WV; Jayathilake K; Lee MA; Meltzer HY
    Psychiatry Res; 2010 Apr; 176(2-3):114-9. PubMed ID: 20199813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melperone, an aytpical antipsychotic drug with clozapine-like effect on plasma prolactin: contrast with typical neuroleptics.
    Bobo WV; Jayathilake K; Lee MA; Meltzer HY
    Hum Psychopharmacol; 2009 Jul; 24(5):415-22. PubMed ID: 19551763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Auditing clinical outcomes after introducing off-licence prescribing of atypical antipsychotic melperone for patients with treatment refractory schizophrenia.
    Röhricht F; Gadhia S; Alam R; Willis M
    ScientificWorldJournal; 2012; 2012():512047. PubMed ID: 22566771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of melperone, an atypical antipsychotic drug, on cognitive function in schizophrenia.
    Sumiyoshi T; Jayathilake K; Meltzer HY
    Schizophr Res; 2003 Jan; 59(1):7-16. PubMed ID: 12413636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of two doses of melperone, an atypical antipsychotic drug, in the treatment of schizophrenia.
    Sumiyoshi T; Jayathilake K; Meltzer HY
    Schizophr Res; 2003 Jul; 62(1-2):65-72. PubMed ID: 12765745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melperone in the treatment of neuroleptic-resistant schizophrenia.
    Meltzer HY; Sumiyoshi T; Jayathilake K
    Psychiatry Res; 2001 Dec; 105(3):201-9. PubMed ID: 11814539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A clinical comparison of melperone and placebo in schizophrenic women on a milieu therapeutic ward.
    Härnryd C; Bjerkenstedt L; Gullberg B
    Acta Psychiatr Scand Suppl; 1989; 352():40-7. PubMed ID: 2573240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical antipsychotic drugs, quetiapine, iloperidone, and melperone, preferentially increase dopamine and acetylcholine release in rat medial prefrontal cortex: role of 5-HT1A receptor agonism.
    Ichikawa J; Li Z; Dai J; Meltzer HY
    Brain Res; 2002 Nov; 956(2):349-57. PubMed ID: 12445705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antipsychotic polypharmacy and augmentation strategies prior to clozapine initiation: a historical cohort study of 310 adults with treatment-resistant schizophrenic disorders.
    Thompson JV; Clark JM; Legge SE; Kadra G; Downs J; Walters JT; Hamshere ML; Hayes RD; Taylor D; MacCabe JH
    J Psychopharmacol; 2016 May; 30(5):436-43. PubMed ID: 26905920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome following clozapine discontinuation: a retrospective analysis.
    Atkinson JM; Douglas-Hall P; Fischetti C; Sparshatt A; Taylor DM
    J Clin Psychiatry; 2007 Jul; 68(7):1027-30. PubMed ID: 17685738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoamine metabolite levels in cerebrospinal fluid of psychotic women treated with melperone or thiothixene.
    Bjerkenstedt L; Gullberg B; Härnryd C; Sedvall G
    Arch Psychiatr Nervenkr (1970); 1977 Oct; 224(2):107-18. PubMed ID: 21644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aripiprazole in treatment-refractory schizophrenia.
    Hsu WY; Lee CI; Chiu NY; Kahn DA
    J Psychiatr Pract; 2009 May; 15(3):221-6. PubMed ID: 19461396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clozapine and risperidone in moderately refractory schizophrenia: a 6-month randomized double-blind comparison.
    Schooler NR; Marder SR; Chengappa KN; Petrides G; Ames D; Wirshing WC; McMeniman M; Baker RW; Parepally H; Umbricht D; Kane JM
    J Clin Psychiatry; 2016 May; 77(5):628-34. PubMed ID: 27035871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.
    Lewis SW; Davies L; Jones PB; Barnes TR; Murray RM; Kerwin R; Taylor D; Hayhurst KP; Markwick A; Lloyd H; Dunn G
    Health Technol Assess; 2006 May; 10(17):iii-iv, ix-xi, 1-165. PubMed ID: 16707074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melperone in low doses in anxious neurotic patients. A double-blind placebo-controlled clinical study.
    Pöldinger WJ
    Neuropsychobiology; 1984; 11(3):181-6. PubMed ID: 6147789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of schizophrenia with melperone augmentation in a patient with phenotypic CYP2D6 ultrarapid metabolization: a case report.
    Gahr M; Gastl R; Kölle MA; Schönfeldt-Lecuona C; Freudenmann RW
    J Med Case Rep; 2012 Feb; 6():49. PubMed ID: 22309430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amisulpride augmentation in clozapine-unresponsive schizophrenia (AMICUS): a double-blind, placebo-controlled, randomised trial of clinical effectiveness and cost-effectiveness.
    Barnes TR; Leeson VC; Paton C; Marston L; Davies L; Whittaker W; Osborn D; Kumar R; Keown P; Zafar R; Iqbal K; Singh V; Fridrich P; Fitzgerald Z; Bagalkote H; Haddad PM; Husni M; Amos T
    Health Technol Assess; 2017 Sep; 21(49):1-56. PubMed ID: 28869006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Augmentation strategies in partial responder and/or treatment-resistant schizophrenia patients treated with clozapine.
    Muscatello MR; Bruno A; De Fazio P; Segura-Garcia C; Pandolfo G; Zoccali R
    Expert Opin Pharmacother; 2014 Nov; 15(16):2329-45. PubMed ID: 25284216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in the pharmacotherapy of schizophrenia.
    Meltzer HY; Lee MA; Ranjan R
    Acta Psychiatr Scand Suppl; 1994; 384():95-101. PubMed ID: 7533472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.